Yesintek, formerly known as Bmab 1200, is a human interleukin-12 and -23 antagonist. The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of ...

YESINKTEK is the sixth ustekinumab biosimilar approved by the FDA, behind Amgen’s WEZLANA (ustekinumab-auub), approved in Oct. 2023; Alvotech’s SELARSDI (ustekinumab-aekn), approved in April 2024; ...

Biocon Ltd. sold Syngene shares worth Rs 686 crore via block deals on the BSE, reducing its stake while maintaining majority ownership at 52.46%.

Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming ...

YESINTEK, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis ...

Bangalore: In a recent BSE filing, Biocon has informed that the U.S. Food and Drug Administration (US FDA) has issued an ...

Laurus Labs Ltd today announced that its subsidiary, Laurus Bio, has signed a definitive agreement for an equity investment ...

5 years ago today, the residents of Bougainville, an autonomous region in Papua New Guinea, voted in a 98% majority for independence of their ...

Following the sale, Biocon’s shareholding in Syngene has come down to 52.46%. Shares of Biocon Ltd ended at ₹368.25, down by ...

Dec. 5, 2024 — The fungus that causes coffee wilt disease repeatedly took up segments of DNA from a related fungal pathogen, which contributed to successive ...

Police Say Suspect’s Notebook Described Motive for C.E.O. Killing The man who has been charged with killing Brian Thompson was found with a notebook that detailed plans for the shooting ...

South Africa sweep Sri Lanka 2-0 to lead World Test Championship table Maharaj’s five-for helps South Africa beat Sri Lanka by 109 runs and leap ahead of Australia and India on the WTC table ...